Evogene (EVGN) Current Assets (2011 - 2025)

Evogene has disclosed Current Assets across 15 years of filings, most recently posting $15.6 million for Q4 2025.

• In Q4 2025, Current Assets fell 27.6% year-over-year to $15.6 million; the TTM figure through Dec 2025 stood at $15.6 million (down 27.6% YoY), while the FY2025 annual figure was $15.6 million, down 27.6% from the prior year.
• Current Assets came in at $15.6 million for Q4 2025 at Evogene, down from $28.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $67.9 million in Q2 2021 to a low of $15.6 million in Q4 2025.
• Average Current Assets over 5 years is $36.2 million, with a median of $35.1 million recorded in 2023.
• Year-over-year, Current Assets surged 70.33% in 2021 and sank 44.44% in 2022.
• Over 5 years, Current Assets stood at $56.9 million in 2021, then tumbled by 33.64% to $37.8 million in 2022, then retreated by 8.69% to $34.5 million in 2023, then sank by 37.37% to $21.6 million in 2024, then retreated by 27.6% to $15.6 million in 2025.
• Per Business Quant data, the three most recent Current Assets figures were $15.6 million in Q4 2025, $28.6 million in Q2 2025, and $21.6 million in Q4 2024.